|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
ATE212378T1
(de)
|
1993-06-04 |
2002-02-15 |
Whitehead Biomedical Inst |
Stressproteine und ihre verwendung
|
|
ES2216009T3
(es)
|
1994-03-21 |
2004-10-16 |
Rijksuniversiteit Utrecht |
Fragmentos peptidicos de proteinas de estres microbianas y composicion farmaceutica a base de estos para el tratamiento y la prevencion de enfermedades inflamatorias.
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
HU222994B1
(hu)
|
1995-11-02 |
2004-01-28 |
BIOREX Kutató és Fejlesztő Rt. |
Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
CA2265935C
(en)
|
1996-09-20 |
2006-09-05 |
The University Of New Mexico |
Heat shock protein complexes
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
BR9907228A
(pt)
|
1998-01-23 |
2000-10-24 |
Nat Jewish Med & Res Center |
Uso de uma proteìna de choque térmico, processo para proteger um mamìfero de uma doença, formulação para proteger um mamìfero de desenvolver uma doença, uso de uma molécula de ácido nucleico, e processo para prescrever um tratamento para hiper-sensibilidade das vias aéreas ou limitação do fluxo de ar associado com uma doença envolvendo resposta inflamatória
|
|
ES2439014T3
(es)
|
1998-02-20 |
2014-01-21 |
The University Of Miami |
Complejo de péptido antigénico-proteína de choque térmico modificada
|
|
ES2246566T5
(es)
|
1998-03-27 |
2010-10-26 |
Gabriele Prof. Dr. Multhoff |
Aplicacion de proteinas hsp70.
|
|
FR2777890B1
(fr)
|
1998-04-22 |
2000-12-29 |
Roussy Inst Gustave |
Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
|
|
US6274597B1
(en)
|
1998-06-01 |
2001-08-14 |
Mount Sinai School Of Medicine Of New York University |
Method of enhancing lysosomal α-Galactosidase A
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
HU226617B1
(en)
|
1998-12-14 |
2009-04-28 |
Cytrx Corp |
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
|
|
HUP9900475D0
(en)
*
|
1999-02-26 |
1999-04-28 |
Biorex Kutato Fejlesztoe Kft |
O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
|
|
EP1218030A4
(en)
|
1999-09-10 |
2004-09-15 |
Univ Fordham |
METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRANSPLANT REJECTION BY USING HEAT SHOCK PROTEINS
|
|
US20020039583A1
(en)
|
1999-09-30 |
2002-04-04 |
Subjeck John R. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US20030236300A1
(en)
|
1999-10-27 |
2003-12-25 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
AU1582801A
(en)
|
1999-11-05 |
2001-06-06 |
Board Of Regents Of The University Of Nebraska, The |
Methods and compositions for protection against bovine herpesvirus
|
|
US6964851B2
(en)
|
1999-12-07 |
2005-11-15 |
Stressgen Biotechnologies Corp. |
Compositions and methods for detecting stress-inducible proteins
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20020127219A1
(en)
|
1999-12-30 |
2002-09-12 |
Okkels Jens Sigurd |
Lysosomal enzymes and lysosomal enzyme activators
|
|
US20010034042A1
(en)
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
WO2001052890A1
(en)
|
2000-01-21 |
2001-07-26 |
University Of Connecticut Health Center |
Heat shock/stress protein complexes as vaccines against neurodegenerative disorders
|
|
WO2001052877A1
(en)
|
2000-01-21 |
2001-07-26 |
University Of Connecticut Health Center |
Compositions and methods to treat neurodegenerative disorders
|
|
HUP0001583A2
(hu)
|
2000-04-18 |
2002-11-28 |
BIOREX Kutató és Fejlesztő Rt. |
Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
|
|
AU2001269923A1
(en)
|
2000-06-19 |
2002-01-02 |
Genzyme Corporation |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20020037290A1
(en)
|
2000-08-07 |
2002-03-28 |
Armen Garo H. |
Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereof
|
|
US7517948B2
(en)
|
2000-09-13 |
2009-04-14 |
Multimmune Gmbh |
Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof
|
|
AU2001292674A1
(en)
|
2000-09-15 |
2002-04-29 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
|
AU2002239462A1
(en)
|
2000-11-03 |
2002-06-03 |
The Board Of Regents Of The University Of Nebraska |
Compositions for protection against bovine viral diseases
|
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
|
US20020142299A1
(en)
|
2001-01-09 |
2002-10-03 |
Davidson Beverly L. |
PTD-modified proteins
|
|
EP1368039A4
(en)
|
2001-02-20 |
2006-03-29 |
Uab Research Foundation |
AMINOGLYCOSIDE TREATMENT FOR LYSOSOMAL STORAGE DISEASES
|
|
PL375043A1
(en)
|
2001-08-20 |
2005-11-14 |
University Of Connecticut Health Center |
Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin, useful for the treatment of cancer and infectious disease
|
|
WO2003029288A2
(en)
|
2001-09-27 |
2003-04-10 |
I.D.M. Immuno-Designed Molecules |
Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
|
|
HU0103939D0
(en)
*
|
2001-09-27 |
2001-11-28 |
Biorex Kutato Fejlesztoe Kft |
Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
|
|
GB0123756D0
(en)
|
2001-10-03 |
2001-11-21 |
King S College London |
A novel chaperone-type of adjuvant for vaccination - Basic 1
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
ITMI20012573A1
(it)
|
2001-12-06 |
2003-06-06 |
D B P Dev Biotechonologica L P |
Gli acilsalicilati:una nuova classe di induttori di risposta heat shock
|
|
CA2471752A1
(en)
|
2002-01-11 |
2003-07-17 |
Biorex Kutato Es Fejlesztoe Rt. |
Carboxamidine derivatives and their use in the treatment of vascular diseases
|
|
WO2003061684A2
(en)
|
2002-01-24 |
2003-07-31 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Tumour treatment compositions comprising hsp70 and tumour necrosis factor
|
|
EP1572933A4
(en)
|
2002-02-13 |
2007-09-05 |
Univ Duke |
MODULATION OF THE IMMUNE RESPONSE BY POLYPEPTIDES AS AN ANSWER TO NONPEPTIDIC BINDING STRENGTH
|
|
IL148401A0
(en)
|
2002-02-26 |
2002-09-12 |
Hadasit Med Res Service |
Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
|
|
WO2003086452A2
(en)
|
2002-04-05 |
2003-10-23 |
Genzyme Corporation |
Methods of enhancing lysosomal storage disease therapy
|
|
AU2003231098A1
(en)
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
WO2003092624A2
(en)
|
2002-05-02 |
2003-11-13 |
University Of Connecticut Health Center |
Use of heat shock proteins to enhance efficacy of antibody therapeutics
|
|
JP2006507272A
(ja)
|
2002-05-02 |
2006-03-02 |
ユニバーシティー オブ コネティカット ヘルス センター |
熱ショックタンパク質−ペプチド複合体またはα−２−マクログロブリン−ペプチド複合体を含むワクチンに対する免疫応答を増強するための熱ショックタンパク質およびα−２−マクログロブリンの使用
|
|
EP1578364A4
(en)
|
2002-09-16 |
2011-06-08 |
Genentech Inc |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF ILLNESSES OF THE IMMUNE SYSTEM
|
|
ES2396231T3
(es)
|
2003-05-21 |
2013-02-20 |
Biotech Tools S.A. |
Complejo peptídico
|
|
US7244616B2
(en)
|
2003-06-27 |
2007-07-17 |
Bayer Pharmaceuticals Corporation |
Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
|
|
HUP0303584A3
(en)
|
2003-10-30 |
2009-12-28 |
Cytrx Corp |
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
|
|
ATE493432T1
(de)
|
2003-11-12 |
2011-01-15 |
Alfa Biogene Internat B V |
Gewinnung von hitzeschockproteinen
|
|
CN1897957A
(zh)
|
2003-11-25 |
2007-01-17 |
纽约大学西奈山医学院 |
尼曼－皮克病的基于陪伴分子的治疗
|
|
ES2484340T3
(es)
|
2003-12-05 |
2014-08-11 |
Multimmune Gmbh |
Anticuerpos anti hsp70 terapéuticos y diagnósticos
|
|
JP2005306778A
(ja)
|
2004-04-21 |
2005-11-04 |
Basf Ag |
徐放性製剤及びその製造方法
|
|
WO2005102272A2
(en)
*
|
2004-04-21 |
2005-11-03 |
Pfizer Products Inc. |
Sustained-release dosage forms for cabergoline
|
|
US20060009520A1
(en)
|
2004-05-12 |
2006-01-12 |
Tall Alan R |
Retinoid-based methods for altering macrophage cholesterol
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
US7270305B2
(en)
|
2004-06-15 |
2007-09-18 |
The Boeing Company |
Aircraft leading edge apparatuses and corresponding methods
|
|
EA201001086A1
(ru)
*
|
2004-08-13 |
2011-10-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
|
|
AU2005312415B2
(en)
|
2004-12-10 |
2012-02-02 |
Angteq B.V. |
Heat shock proteins (HSP) and supraventricular arrhythmia
|
|
MX2007015602A
(es)
|
2005-06-08 |
2008-02-21 |
Amicus Therapeutics Inc |
Tratamiento de trastornos del sistema nervioso central asociados con mutaciones en genes que codifican las enzimas lisosomicas.
|
|
WO2007041285A2
(en)
|
2005-09-29 |
2007-04-12 |
Viral Genetics, Inc. |
Complexes of inactivated pepsin fraction and heat shock protein
|
|
EP2774925B1
(en)
|
2005-11-08 |
2016-12-28 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic modulators of ATP-binding cassette transporters
|
|
US20080039400A1
(en)
|
2006-01-24 |
2008-02-14 |
Universiteit Utrecht Uu Holding B.V. |
Treatment and prevention of inflammatory bowel diseases
|
|
JP2009525966A
(ja)
|
2006-01-26 |
2009-07-16 |
フォールドアールエックス ファーマシューティカルズ インコーポレーティッド |
タンパク質輸送を調節するための化合物および方法
|
|
BRPI0711950A2
(pt)
|
2006-05-19 |
2011-12-13 |
Scripps Research Inst |
tratamento para o dobramento inadequado da proteìna
|
|
ATE555788T1
(de)
|
2006-06-23 |
2012-05-15 |
Amicus Therapeutics Inc |
Verfahren zur behandlung neurologischer erkrankungen mittels verstärkung der beta - glucocerebrosidaseaktivität
|
|
JP5599610B2
(ja)
|
2006-06-30 |
2014-10-01 |
スローン − ケッタリング インスティチュート フォー キャンサー リサーチ |
Ｈｓｐ９０の阻害による神経変性疾患の処置
|
|
WO2008021210A2
(en)
|
2006-08-11 |
2008-02-21 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
EP2057195A4
(en)
|
2006-08-29 |
2010-05-12 |
Forhumantech Co Ltd |
PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME
|
|
TW200831479A
(en)
*
|
2006-09-26 |
2008-08-01 |
Cytrx Corp |
Pharmaceutical compositions and methods for treating diseases
|
|
EP2089033A2
(en)
|
2006-12-01 |
2009-08-19 |
CytRx Corporation |
Stroke recovery
|
|
CA2680063A1
(en)
|
2007-02-23 |
2008-08-28 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for treating glycogen storage diseases
|
|
EP2155197A4
(en)
|
2007-03-09 |
2011-10-12 |
Link Medicine Corp |
TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
|
GB0705626D0
(en)
|
2007-03-23 |
2007-05-02 |
Royal Veterinary College |
Method for enhancing sperm survival
|
|
WO2008127680A2
(en)
|
2007-04-11 |
2008-10-23 |
The Jackson Laboratory |
Diagnosis and treatment of diseases caused by misfolded proteins
|
|
AU2008240138B2
(en)
|
2007-04-13 |
2013-03-07 |
Amicus Therapeutics, Inc. |
Treatment of Gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
|
|
ES2401205T3
(es)
|
2007-04-25 |
2013-04-17 |
Cytochroma Inc. |
Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
|
|
WO2008134628A2
(en)
|
2007-04-26 |
2008-11-06 |
Amicus Therapeutics, Inc. |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
|
|
ES2963291T3
(es)
*
|
2007-04-26 |
2024-03-26 |
Sublimity Therapeutics Ltd |
Fabricación de múltiples minicápsulas
|
|
TW200901958A
(en)
*
|
2007-05-04 |
2009-01-16 |
Cytrx Corp |
Diabetic wound healing
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
|
JP2010532785A
(ja)
|
2007-07-06 |
2010-10-14 |
ウニベルジテイト・ウトレヒト・ホールディング・ビー．ブイ． |
炎症性疾患および自己免疫疾患の治療および予防
|
|
JP2010538655A
(ja)
|
2007-09-12 |
2010-12-16 |
アナフォア インコーポレイテッド |
自己免疫疾患についてのｈｓｐ７０に基づく治療
|
|
WO2009066069A1
(en)
|
2007-11-21 |
2009-05-28 |
Summit Corporation Plc |
Treatment of protein folding disorders
|
|
EP2211856A4
(en)
|
2007-11-29 |
2011-02-09 |
Hospital For Sick Children |
COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDER
|
|
KR20110007600A
(ko)
|
2008-01-30 |
2011-01-24 |
제론 코포레이션 |
세포배양 제품 및 스크리닝하는 방법
|
|
WO2009095452A1
(en)
|
2008-01-31 |
2009-08-06 |
Crystax Pharmaceuticals, S.L. |
Crystal structure of the atpase domain of proteins of the hsp70 family
|
|
CA2712593A1
(en)
|
2008-02-01 |
2009-08-13 |
The Scripps Research Institute |
Methods for treating a condition characterized by dysfunction in protein homeostasis
|
|
ES2629853T3
(es)
|
2008-05-07 |
2017-08-16 |
Biomarin Pharmaceutical Inc. |
Péptidos de dirección lisosómica y usos de los mismos
|
|
WO2009137796A2
(en)
|
2008-05-08 |
2009-11-12 |
Northwestern University |
Method of regulating the heat shock response
|
|
GB0809360D0
(en)
|
2008-05-22 |
2008-07-02 |
Isis Innovation |
Calcium modulation
|
|
EP2484371B1
(en)
*
|
2008-06-26 |
2014-12-17 |
Orphazyme APS |
Use of Hsp70 as a regulator of enzymatic activity
|
|
WO2010015816A2
(en)
|
2008-08-06 |
2010-02-11 |
Summit Corporation Plc |
Treatment of lysosomal storage disorders and other proteostatic diseases
|
|
WO2010022461A1
(en)
|
2008-08-29 |
2010-03-04 |
Children, Youth And Women's Health Service |
Sulphated sugars to increase activity of sulphatases en lysosomal storage disorders
|
|
AU2009296271A1
(en)
|
2008-09-29 |
2010-04-01 |
Vertex Pharmaceuticals Incorporated |
Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
|
WO2010053655A2
(en)
|
2008-11-07 |
2010-05-14 |
University Of Kansas |
Therapeutic methods with withaferin a and analogs
|
|
WO2010086418A1
(en)
|
2009-01-29 |
2010-08-05 |
Alfa Biogene International B.V. |
Functional food product comprising heat shock protein or a hydrolysate thereof
|
|
EP2218458A1
(en)
|
2009-02-13 |
2010-08-18 |
Fondazione Telethon |
Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
|
|
US8932571B2
(en)
|
2009-03-10 |
2015-01-13 |
Alfa Biogene International B.V. |
Skin care product
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
EP2475376B1
(en)
|
2009-06-17 |
2016-03-30 |
BioMarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
NZ623910A
(en)
|
2009-07-28 |
2016-06-24 |
Shire Human Genetic Therapies |
Compositions and methods for treating gaucher disease
|
|
WO2011019763A2
(en)
|
2009-08-10 |
2011-02-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
|
|
US20110081428A1
(en)
|
2009-09-16 |
2011-04-07 |
The Buck Institute For Age Research |
Use of thioflavin-like compounds to increase life span and/or health span
|
|
WO2011075686A2
(en)
|
2009-12-18 |
2011-06-23 |
Ventria Bioscience |
Methods & compositions comprising heat shock proteins
|
|
CN102791258B
(zh)
|
2010-02-03 |
2018-05-08 |
图必制药公司 |
雷沙吉兰的延长释放制剂及其用途
|
|
ES2688072T3
(es)
*
|
2010-05-11 |
2018-10-30 |
Mallinckrodt Ard Ip Limited |
ACTH para el tratamiento de la esclerosis lateral amiotrófica
|
|
WO2012012656A2
(en)
|
2010-07-21 |
2012-01-26 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
RU2013125923A
(ru)
|
2010-11-30 |
2015-01-10 |
Орфазиме Апс |
СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
|
|
WO2013006076A1
(en)
|
2011-07-04 |
2013-01-10 |
New York University |
The use of intranasally administered hsp70 protein to treat neurodegenerative diseases
|
|
EP2763663B1
(en)
|
2011-10-06 |
2017-12-27 |
Novartis AG |
Pharmaceutical compositions comprising 40-o-(2-hydroxy)ethyl-rapamycin
|
|
AU2013240187A1
(en)
|
2012-03-28 |
2014-10-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
BR112015009746A2
(pt)
|
2012-11-05 |
2017-08-15 |
Genzyme Corp |
Agente que aumenta atividade de glicocerebrosidase em mamíferos
|
|
US10709700B2
(en)
|
2014-09-15 |
2020-07-14 |
Orphazyme A/S |
Arimoclomol formulation
|
|
JP2020520947A
(ja)
|
2017-05-24 |
2020-07-16 |
オーファザイム エー／エス |
熱ショックタンパク質誘導因子および前頭側頭障害
|